Abstract:
Rheumatoid arthritis (RA), a chronic systemic inflammatory disease,
predominantly affects the joints, leading to functional disability and premature mortality.
Standards of care have been established for its treatment. Its management include early
aggressive, and persistent use of disease-modifying antirheumatic drugs (DMARDs) to
prevent joint damage in people with active inflammation. However, published evidence and
guidance for its clinical management are lacking in resource limited countries such as
Ethiopia. This research assesses whether care for RA is consistent with current treatment
guidelines.